Woodline Partners LP Argenx Se Transaction History
Woodline Partners LP
- $19.5 Billion
- Q3 2025
A detailed history of Woodline Partners LP transactions in Argenx Se stock. As of the latest transaction made, Woodline Partners LP holds 169,476 shares of ARGX stock, worth $154 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
169,476
Previous 40,271
320.84%
Holding current value
$154 Million
Previous $22.2 Million
463.1%
% of portfolio
0.64%
Previous 0.13%
Shares
14 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...